EN #FDA 9/3/26 FDA's New Pilot Program Clears Path for Artificial Intelligence Devices The TEMPO program temporarily facilitates the market introduction of certain artificial intelligence-powered medical devices. Artificial Intelligence News
EN #FDA 9/2/26 US Medical Organizations Issue Fall Vaccine Recommendations Leading US medical organizations have released their autumn flu and Covid-19 vaccine guidelines to clear up confusion caused by changing official recommendations. News World
EN #FDA 8/26/26 FDA Approval for Abbott's World's First Dual-Sensor Device for Diabetes Patients Abbott has received approval from the U.S. Food and Drug Administration for the world's first dual-sensor system that helps prevent diabetic ketoacidosis by tracking ketone levels in diabetes patients. News World
